Cytokine Release Syndrome (CRS) is an acute systemic inflammatory response syndrome that can arise as a complication of certain cancer immunotherapies, such as CAR T-cell therapy and monoclonal antibodies. It results from excessive and uncontrolled release of pro-inflammatory cytokines by immune cells, often leading to severe symptoms and requiring immediate medical intervention.
